Medtronic announces FDA approval of Simplera™ CGM and global partnership with Abbott
- Written by PR Newswire
 |
Medtronic Diabetes expands CGM offerings to meet more people where they are in their diabetes journey
DUBLIN, Aug. 7, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval for its Simplera™ continuous glucose monitor (CGM) — the...
